Dr. Charles Drake, an immunotherapy expert, delivered the immunotherapy for mCRPC at the management of CRPC session at the Advanced Prostate Cancer Consensus Conference (APCCC), 2019 in Basel, Switzerland. Regarding the III IMPACT clinical trial, UroToday reports, “An...